Metraipolis › archive › dc_620daa480b3c

Intratumoral B cell and interferon signatures in newly diagnosed glioblastoma are associated with longer survival in patients treated with SurVaxM — Europe PMC PMID:41066027

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41066027
DOI
10.1007/s00262-[numero omesso]-y
License (as archived)
solo-consultazione
Archived
2026-11-09T11:21:36.325Z
SHA-256 of the archived text
b2dd6d49fff61c5b5bad0527cb4af0b499da633b5b2146258b4c7e2473528395
Stable URL of this page
https://metraipolis.com/documento/dc_620daa480b3c

How to cite

Intratumoral B cell and interferon signatures in newly diagnosed glioblastoma are associated with longer survival in patients treated with SurVaxM — Europe PMC PMID:41066027 — Europe PMC (en), https://europepmc.org/article/MED/41066027 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_620daa480b3c (Metraipolis archive dc_620daa480b3c, sha256 b2dd6d49fff61c5b5bad0527cb4af0b499da633b5b2146258b4c7e2473528395)
BibTeX
@misc{dc620daa480b3c,
  title = {Intratumoral B cell and interferon signatures in newly diagnosed glioblastoma are associated with longer survival in patients treated with SurVaxM — Europe PMC PMID:41066027},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41066027},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_620daa480b3c; sha256 b2dd6d49fff61c5b5bad0527cb4af0b499da633b5b2146258b4c7e2473528395},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41066027. Agents can read the archived copy with the MCP tool read_document.